Medix Inc.
Industry
- Distributors
- Medical Devices
See more in Biomedtracker
Latest on Medix Inc.
Generics Bulletin
• By Anju Ghangurde
Things may be looking up in the US for adalimumab biosimilars, but Coherus BioSciences, Inc. 's decision to divest Yusimry (adalimumab-aqvh) saw analysts raise questions on the wider prospects for ri
Scrip
• By Anju Ghangurde
Things may be looking up in the US for adalimumab biosimilars, but Coherus BioSciences, Inc. 's decision to divest Yusimry (adalimumab-aqvh) saw analysts raise questions on the wider prospects for ri
Scrip
• By Lubna Ahmed
The US obesity market is set to grow from $533m to $1.2bn in the next 10 years, according to Datamonitor Healthcare’s obesity forecast . However, there is room for more dramatic growth long term sh